2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$13.21+$0.05 (+0.40%)
Price as of Aug 21, 2026 7:57 PM EDT- $10.5BMarket Cap
- -49.77%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$13.21+$0.05 (+0.40%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.16 | ||
Change | +$0.73 (+5.87%) | ||
Open | $12.69 | ||
High | $13.53 | ||
Low | $12.57 | ||
Previous Close | $12.43 | ||
Volume | 7,074,307 | ||
30-Day Average Volume | 4,947,298 | ||
1-Week Change | -1.42% | ||
1-Month Change | -10.05% | ||
1-Year Change | -49.77% | ||
3-Year Change | 585.42% | ||
5-Year Change | 70.91% | ||
Fundamentals | |||
Shares Outstanding | 797.7M | ||
Total Assets | $752.2M | ||
Market Cap | $10.5B | ||
Enterprise Value | $10.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$215.7M | ||
Free Cash Flow | -$142.0M | ||
EBIT | -$215.7M | ||
EBITDA | -$215.7M | ||
Net Working Capital | $617.0M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 17 | ||
P/E | -47 | ||
PEG | 3 | ||
Price/Free Cash Flow | -74 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue